Pentobarbital produces dissimilar changes in glucose influx and utilization in brain
- PMID: 1877685
- DOI: 10.1152/ajpregu.1991.261.2.R265
Pentobarbital produces dissimilar changes in glucose influx and utilization in brain
Abstract
The effects of pentobarbital sodium on local cerebral glucose utilization (LCGU) and 3-O-methylglucose (3-MG) influx were measured by quantitative autoradiography in 52 brain areas of control and treated rats. Pentobarbital (50 mg/kg ip) lowered LCGU to a relatively uniform rate (approximately 35 mumol.100 g-1.min-1) in 24 of 25 forebrain areas. Among the 18 hindbrain areas, LCGU was decreased by pentobarbital by 15-55% (range 50-157 and 28-110 mumol.100 g-1.min-1 in control and treated rats, respectively). In contrast, pentobarbital lowered the 3-MG influx rate constant and permeability-surface area product by 20-30% in nearly all brain structures. The 3-MG results fit a model in which both the half-saturation constant and the maximal velocity of the glucose carrier are decreased by pentobarbital. After pentobarbital treatment, the ratio of local cerebral plasma flow (LCPF) to LCGU was the same as in controls for brain areas in which LCGU was less than 35 mumol.100 g-1.min-1 but was higher in brain areas where LCGU exceeded 35 mumol.100 g-1.min-1. Pentobarbital produced dissimilar changes in LCGU, 3-MG influx, and LCPF; these processes may thus not be closely linked during pentobarbital anesthesia.
Similar articles
-
A TRH analog (DN-1417): effects on local cerebral glucose utilization in conscious and pentobarbitalized rats determined by the autoradiographic 2-deoxy-[14C]glucose method.Jpn J Pharmacol. 1983 Jun;33(3):635-45. doi: 10.1254/jjp.33.635. Jpn J Pharmacol. 1983. PMID: 6413736
-
Brain injury: new insights into neurotransmitter and receptor mechanisms.Neurochem Res. 1991 Sep;16(9):941-9. doi: 10.1007/BF00965837. Neurochem Res. 1991. PMID: 1664496 Review.
-
Measurement of cerebral glucose utilization from brain uptake of [14C]2-deoxyglucose and [3H]3-O-methylglucose in the mouse.J Pharmacol Methods. 1990 Apr;23(2):129-40. doi: 10.1016/0160-5402(90)90040-r. J Pharmacol Methods. 1990. PMID: 2110275
-
Influence of glucose supply and demand on determination of brain glucose content with labeled methylglucose.J Cereb Blood Flow Metab. 1996 May;16(3):439-49. doi: 10.1097/00004647-199605000-00010. J Cereb Blood Flow Metab. 1996. PMID: 8621748
-
[Local cerebral glucose utilization in the ethylnitrosourea-induced rat glioma].No To Shinkei. 1982 Aug;34(8):755-9. No To Shinkei. 1982. PMID: 7126378 Japanese.
Cited by
-
Brain metabolite levels assessed by lactate-edited MR spectroscopy in premature neonates with and without pentobarbital sedation.AJNR Am J Neuroradiol. 2008 Apr;29(4):798-801. doi: 10.3174/ajnr.A0912. Epub 2008 Jan 9. AJNR Am J Neuroradiol. 2008. PMID: 18184837 Free PMC article.
-
Piracetam and TRH analogues antagonise inhibition by barbiturates, diazepam, melatonin and galanin of human erythrocyte D-glucose transport.Br J Pharmacol. 2004 Jun;142(3):594-608. doi: 10.1038/sj.bjp.0705798. Epub 2004 May 17. Br J Pharmacol. 2004. PMID: 15148255 Free PMC article.
-
In normal rat, intraventricularly administered insulin-like growth factor-1 is rapidly cleared from CSF with limited distribution into brain.Cerebrospinal Fluid Res. 2005 Jul 26;2:5. doi: 10.1186/1743-8454-2-5. Cerebrospinal Fluid Res. 2005. PMID: 16045806 Free PMC article.
-
Metabolic-dopaminergic mapping of the 6-hydroxydopamine rat model for Parkinson's disease.Eur J Nucl Med Mol Imaging. 2008 Jan;35(1):124-34. doi: 10.1007/s00259-007-0558-3. Epub 2007 Sep 29. Eur J Nucl Med Mol Imaging. 2008. PMID: 17906859
-
The quest for a better insight into physiology of fluids and barriers of the brain: the exemplary career of Joseph D. Fenstermacher.Fluids Barriers CNS. 2015 Jan 12;12:1. doi: 10.1186/2045-8118-12-1. eCollection 2015. Fluids Barriers CNS. 2015. PMID: 25745556 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous